A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection.
BACKGROUND
Diagnosis of neonatal infection is difficult, because of it's non-specific clinical presentation and the lack of reliable diagnostic tests. The purpose of this study was to examine the potential diagnostic value of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble E-selectin (sE-selectin), highly sensitive C-reactive protein (hsCRP) and serum amyloid A (SAA) measurements, both individually and in combination in the setting of a neonatal intensive care unit.


METHODS
219 consecutive serum samples were taken from 149 infants undergoing sepsis work up in a neonatal intensive care unit. Clinical diagnosis was established in a prospective manner, blind to the results of the study measurements. Infants were classified by an experienced paediatrician as infected or not-infected, one week after presentation. Classification was based on clinical presentation, routine laboratory and radiological investigations and response to therapy. The infected group were sub-classified as (a) culture positive infection or (b) culture negative infection. sICAM-1, sE-selectin, hsCRP and SAA levels were determined from stored serum samples after diagnosis was established. Further sub-group analysis of results was undertaken according to early or late onset of infection and preterm or term status. Statistical analysis utilised Mann Whitney U test and ROC curve analysis.


RESULTS
There were significantly increased serum levels of sICAM-1, hsCRP, E selectin (p < 0.001) and SAA (p = 0.004) in infected infants compared with non-infected. ROC curve analysis indicated area under the curve values of 0.79 (sICAM-1), 0.73 (hsCRP), 0.72 (sE-selectin) and 0.61 (SAA). ROC curve analysis also defined optimum diagnostic cut-off levels for each measurement. The performance characteristics of sICAM-1, hsCRP and sE-selectin included a high negative predictive value (NPV) for culture positive infection and this was enhanced by combination of all 4 measurements. Clinical subgroup analysis suggested particularly high NPV for early onset symptoms, however further studies are required to elucidate this finding.


CONCLUSIONS
All four study measurements demonstrated some diagnostic value for neonatal infection however sICAM-1, hsCRP and sE-selectin demonstrated the highest NPV individually. The optimum diagnostic cut off level for hsCRP measurement in this study was much lower than currently used in routine clinical practice. Use of a combination of measurements enhanced diagnostic performance, demonstrating sensitivity of 90.3% and NPV of 91.3%. This study suggests there may be value in use of several of these markers, individually and in combination to assist in excluding neonatal infection. Further work is needed to confirm a specific role in the exclusion of early onset infection.
Edgar
J David M
JD
Regional Immunology Service, Royal Hospitals, The Belfast Trust, & School of Medicine, Dentistry & Biomedical Sciences, Queen's University Belfast, Northern Ireland. david.edgar@belfasttrust.hscni.net
Gabriel
Vanessa
V
Gallimore
J Ruth
JR
McMillan
Stanley A
SA
Grant
Judith
J
D002097:C-Reactive Protein / Q000378:metabolism*; D003937:Diagnosis, Differential; D019040:E-Selectin / Q000097:blood*; D004739:England; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000097:blood* / Q000175:diagnosis; D007239:Infections / Q000097:blood / Q000175:diagnosis*; D007363:Intensive Care Units, Neonatal; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008297:Male; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012372:ROC Curve; D012680:Sensitivity and Specificity; D018805:Sepsis / Q000175:diagnosis; D000685:Serum Amyloid A Protein / Q000378:metabolism
D019040:E-Selectin; D000685:Serum Amyloid A Protein; D018799:Intercellular Adhesion Molecule-1; D002097:C-Reactive Protein
Acta Paediatr. 2008 Aug;97(8):1061-5
18510717
Pediatrics. 2005 Nov;116(5):1070-4
16263991
J Pediatr. 1997 Jan;130(1):166
9003874
Eur J Pediatr. 1990 Mar;149(6):424-7
2332012
Acta Paediatr. 1997 Mar;86(3):274-80
9099317
Biol Neonate. 2005;87(2):111-2
15539767
Mol Cell Proteomics. 2008 Oct;7(10):1863-75
18622029
Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F229-35
15102726
Pathology. 2008 Feb;40(2):141-8
18203036
Clin Sci (Lond). 1994 Aug;87(2):165-71
7924161
Biol Neonate. 2002;81(2):105-8
11844879